Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01842932Phase 4Unknown
Phase 4, randomised, double-blind trial comparing Phloroglucin & Placebo with Cimetropium bromide & Placebo (2 arms). Primary endpoint: Non-inferiority of phloroglucin to cimetropium bromide at 10 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01842932.